FFA
First Foundation Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | – | Sell |
-24,510
| Closed | -$378K | – | 380 |
|
2018
Q4 | $378K | Buy |
+24,510
| New | +$378K | 0.02% | 294 |
|
2017
Q3 | – | Sell |
-105,803
| Closed | -$3.52M | – | 335 |
|
2017
Q2 | $3.52M | Buy |
105,803
+8,674
| +9% | +$288K | 0.21% | 70 |
|
2017
Q1 | $3.12M | Buy |
97,129
+6,406
| +7% | +$206K | 0.19% | 75 |
|
2016
Q4 | $3.29M | Sell |
90,723
-25,932
| -22% | -$940K | 0.22% | 80 |
|
2016
Q3 | $5.37M | Buy |
116,655
+3,072
| +3% | +$141K | 0.37% | 53 |
|
2016
Q2 | $5.71M | Buy |
113,583
+13,298
| +13% | +$668K | 0.41% | 55 |
|
2016
Q1 | $5.37M | Buy |
100,285
+30,956
| +45% | +$1.66M | 0.39% | 57 |
|
2015
Q4 | $4.55M | Sell |
69,329
-24,501
| -26% | -$1.61M | 0.31% | 67 |
|
2015
Q3 | $5.3M | Buy |
93,830
+41,872
| +81% | +$2.36M | 0.44% | 55 |
|
2015
Q2 | $3.07M | Buy |
51,958
+12,061
| +30% | +$713K | 0.24% | 65 |
|
2015
Q1 | $2.49M | Buy |
39,897
+4,818
| +14% | +$300K | 0.21% | 65 |
|
2014
Q4 | $2.02M | Buy |
35,079
+3,710
| +12% | +$213K | 0.18% | 71 |
|
2014
Q3 | $1.69M | Buy |
31,369
+6,002
| +24% | +$323K | 0.17% | 64 |
|
2014
Q2 | $1.33M | Buy |
25,367
+5,897
| +30% | +$309K | 0.15% | 65 |
|
2014
Q1 | $1.03M | Buy |
19,470
+1,255
| +7% | +$66.3K | 0.13% | 62 |
|
2013
Q4 | $730K | Sell |
18,215
-285,713
| -94% | -$11.5M | 0.1% | 73 |
|
2013
Q3 | $11.5M | Buy |
303,928
+11,740
| +4% | +$444K | 1.79% | 25 |
|
2013
Q2 | $11.5M | Buy |
+292,188
| New | +$11.5M | 2.24% | 20 |
|